{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:28:51Z","timestamp":1791152931727,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.metabol.2012.08.005","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T00:39:12Z","timestamp":1348015152000},"page":"352-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not"],"prefix":"10.1016","volume":"62","author":[{"given":"Zobair M.","family":"Younossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munkhzul","family":"Otgonsuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chapy","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.08.005_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"Mishra","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2012.08.005_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2012.08.005_bb0015","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2012.08.005_bb0020","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/jhep.2002.32483","article-title":"Non-alcoholic fatty liver disease: an agenda for clinical research","volume":"35","author":"Younossi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S1262-3636(08)74597-X","article-title":"Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis","volume":"34","author":"Serfaty","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2012.08.005_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.22140","article-title":"The future is around the corner: noninvasive diagnosis of progressive nonalcoholic steatohepatitis","volume":"47","author":"Baranova","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2012.08.005_bb0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2012.08.005_bb0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.metabol.2012.08.005_bb0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Non-alcoholic fatty liver disease in patients with type II diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.metabol.2012.08.005_bb0075","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gut.2010.213553","article-title":"Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study","volume":"59","author":"Stepanova","year":"2010","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.metabol.2012.08.005_bb0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2036.2011.04579.x","article-title":"Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease","volume":"33","author":"Baranova","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.metabol.2012.08.005_bb0085","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.24769","article-title":"Potential mechanisms underlying the associations between liver enzymes and risk for type 2 diabetes","volume":"55","author":"Venkatesan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0090","article-title":"Prevalence and independent predictors of lean non-alcoholic fatty liver disease: a population based data","author":"Younossi","year":"2012","journal-title":"Medicine"},{"key":"10.1016\/j.metabol.2012.08.005_bb0095","article-title":"Anthropometric and clinical factors associated with mortality in subjects with non-alcoholic fatty liver disease","author":"Otgonsuren","year":"2012","journal-title":"Dig Dis Sciences"},{"issue":"4","key":"10.1016\/j.metabol.2012.08.005_bb0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2012.08.005_bb0105","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1572-0241.2008.02034.x","article-title":"Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study","volume":"103","author":"Dunn","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.metabol.2012.08.005_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","article-title":"Fatty liver index and mortality: the Cremona study in the 15th year of follow-up","volume":"54","author":"Calori","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0115","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/gut.2010.230656","article-title":"Risk of all-cause and cardiovascular mortality in patients with chronic liver disease","volume":"60","author":"Targher","year":"2011","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.metabol.2012.08.005_bb0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease","volume":"43","author":"Musso","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.metabol.2012.08.005_bb0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","article-title":"Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2012.08.005_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.metabol.2012.08.005_bb0135","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.metabol.2012.08.005_bb0140","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/dc09-0574","article-title":"Are metabolically normal but obese individuals at lower risk for all-cause mortality?","volume":"32","author":"Kuk","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metabol.2012.08.005_bb0145","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.orcp.2011.04.003","article-title":"Dysmetabolic signals in \u201cmetabolically healthy\u201d obesity","volume":"6","author":"Manu","year":"2012","journal-title":"Obes Res Clin Pract."},{"issue":"19","key":"10.1016\/j.metabol.2012.08.005_bb0150","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2012.08.005_bb0155","series-title":"Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988\u201394)","author":"CDC\/NCHS","year":"1996"},{"issue":"12","key":"10.1016\/j.metabol.2012.08.005_bb0160","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/sj.ijo.0802167","article-title":"Body composition estimates from NHANES III bioelectrical impedance data","volume":"26","author":"Z Chumlea","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2012.08.005_bb0165","series-title":"Third National Health and Nutrition Examination Survey, 1988\u20131994, NHANES III hepatic steatosis ultrasound images assessment procedures manual","author":"US Department of Health and Human Services (DHHS), National Center for Health Statistics","year":"2010"},{"key":"10.1016\/j.metabol.2012.08.005_bb0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2012.08.005_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diabres.2011.08.013","article-title":"Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease?","volume":"95","author":"Seo","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"13","key":"10.1016\/j.metabol.2012.08.005_bb0180","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","article-title":"Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2012.08.005_bb0185","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2012.08.005_bb0190","first-page":"RA23","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know","volume":"12","author":"Akbar","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.metabol.2012.08.005_bb0195","doi-asserted-by":"crossref","unstructured":"Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population based study. Aliment Pharm Ther 2011 [in press].","DOI":"10.1111\/apt.12038"},{"issue":"5","key":"10.1016\/j.metabol.2012.08.005_bb0200","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.metabol.2012.08.005_bb0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15288\/jsa.1994.55.133","article-title":"Measurement of lifetime alcohol consumption","volume":"55","author":"Chaikelson","year":"1994","journal-title":"J Stud Alcohol"},{"issue":"7","key":"10.1016\/j.metabol.2012.08.005_bb0210","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1360-0443.1992.tb03118.x","article-title":"Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity","volume":"87","author":"Brown","year":"1992","journal-title":"Br J Addict"},{"issue":"1","key":"10.1016\/j.metabol.2012.08.005_bb0215","first-page":"29","article-title":"A 2012 clinical update for internists in adult nonalcoholic fatty liver disease","volume":"54","author":"Younossi","year":"2012","journal-title":"Panminerva Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512003095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:58:58Z","timestamp":1758427138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512003095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0026049512003095"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.08.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}